Masao Ono

Title: **Masao Ono: Pioneering Type III Allergic Inflammation Research**

Introduction

Masao Ono, a dedicated inventor based in Sendai, Japan, has made significant strides in the field of allergic inflammation research. With a focus on developing innovative experimental models, he has contributed to the understanding of Type III allergies, which has far-reaching implications for medical science.

Latest Patents

Masao Ono holds a notable patent titled "Type III Allergic Inflammation Model Animal." This invention presents an experimental model that does not lead to anaphylaxis, a Type I allergy. Instead, it specifically induces the Arthus reaction, a Type III allergy, providing a targeted means to evaluate Type III allergy inflammation. The model allows researchers to screen for substances that can accelerate or inhibit reactions in Type III allergy through FcγRIII. The innovative aspect of his invention lies in the creation of a mouse with a deletion mutation in both Lyn and FcγRIIB molecules, known as LynIIB. This model enhances the measurement of FcγRIII function deficiencies and its reduction in bone marrow-derived mast cells, advancing the study of allergic responses.

Career Highlights

Currently, Masao Ono is affiliated with the Japan Science and Technology Agency, where he continues to innovate and contribute to the field of allergy research. His expertise in creating experimental models is invaluable in understanding the complexities of allergic reactions, particularly Type III allergies.

Collaborations

Masao Ono has collaborated with esteemed colleagues, including Toshiyuki Takai and Takae Yuasa. These collaborations have further enriched his research, allowing for a multidisciplinary approach to studying allergic inflammation and developing new therapeutic strategies.

Conclusion

Masao Ono's contributions to the field of allergic inflammation highlight the importance of innovative research in understanding complex health issues. His patented model serves as a critical tool for researchers, paving the way for advancements in allergy treatment and management. Through his work at the Japan Science and Technology Agency and collaboration with fellow researchers, Ono continues to impact the scientific community positively.